CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: ZNF700 (ImmuneEditome ID:90592)

1. Gene summary of enriched editing regions for ZNF700

check button Gene summary
Gene informationGene symbol

ZNF700

Gene ID

90592

GeneSynonyms-
GeneCytomap

19p13.2

GeneTypeprotein-coding
GeneDescriptionzinc finger protein 700
GeneModificationdate20230329
UniprotIDQ9H0M5;K7EQV7;A0A087WVH9
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr19:11926444-11929455:+ENST00000254321.8ENSG00000196757.6ZNF700intronicMER49,MER57E3,LTR24C,AluJo,AluJr,MER41D,AluYa5,FLAM_A,AluSzchr19:11926444-11929455:+.alignment
chr19:11926444-11929455:+ENST00000622593.3ENSG00000196757.6ZNF700intronicMER49,MER57E3,LTR24C,AluJo,AluJr,MER41D,AluYa5,FLAM_A,AluSzchr19:11926444-11929455:+.alignment
chr19:11930696-11935452:+ENST00000254321.8ENSG00000196757.6ZNF700intronicAluSp,AluY,AluYf1,L1MC2,AluYc,L1ME3B,L1M5,AluSq2,AluSg,MLT1A,FLAM_C,AluSz6,AluJrchr19:11930696-11935452:+.alignment
chr19:11930696-11935452:+ENST00000622593.3ENSG00000196757.6ZNF700intronicAluSp,AluY,AluYf1,L1MC2,AluYc,L1ME3B,L1M5,AluSq2,AluSg,MLT1A,FLAM_C,AluSz6,AluJrchr19:11930696-11935452:+.alignment


Top

2. Tumor-specific enriched editing regions for ZNF700


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
ENSG00000196757.6,ZNF700ESCAEAG2.4383e-024.5353e-021.6387e+01image

Top

3. Enriched editing regions and immune related genes for ZNF700


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr19:11926444-11929455:+LAMLEERENSG00000267274,CTD-2006C1.12-0.54781.5014e-063.9158e-12-0.5278imageNBCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;KHDRBS1;LSM11;NOP56;SLTM;SMNDC1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000196757,ZNF700-0.53861.1101e-051.7493e-11-0.5139imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_IL2_STAT5_SIGNALING
chr19:11926444-11929455:+LAMLEERENSG00000147789,ZNF7-0.51787.1357e-058.0895e-09-0.4492imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr19:11926444-11929455:+LAMLEERENSG00000189180,ZNF33A-0.49131.0695e-042.7532e-09-0.4616imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAEosinophilsGSVA_HALLMARK_NOTCH_SIGNALING
chr19:11926444-11929455:+LAMLEERENSG00000272140,RP11-574K11.29-0.50081.4348e-048.1023e-10-0.4751imageNBUD13;CPSF6;CSTF2T;ELAVL1;GTF2F1;HNRNPA1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;LSM11;NOP56;SLTM;SMNDC1;SRSF1;SRSF9;TAF15;U2AF2;XRN2;RBFOX2;RBM27;TIA1;TROVE2NAT_cells_CD4_naiveGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000250903,GMDS-AS1-0.48534.9949e-041.0144e-08-0.4466imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000180855,ZNF443-0.47494.9949e-045.0499e-08-0.4270imageNBUD13;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;KHDRBS1;NOP56;SAFB2;SLTM;SRSF1;SRSF9;TAF15;U2AF2;HNRNPL;KHSRP;NONO;RBFOX2;TIA1ZNF443MonocytesGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB
chr19:11926444-11929455:+LAMLEERENSG00000263477,RP11-338L22.2-0.47445.3780e-043.8511e-08-0.4304imageNELAVL1;NOP56NAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000265713,RP11-82O19.2-0.46128.5624e-044.2849e-10-0.4819imageNNNAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000225891,RP3-476K8.3-0.47448.5624e-045.8098e-08-0.4253imageNCSTF2T;ELAVL1;HNRNPA1;HNRNPA2B1;HNRNPC;IGF2BP2;SLTM;SRSF1;TAF15;U2AF2;RBFOX2;TIA1;TROVE2NANeutrophilsGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSE
chr19:11926444-11929455:+LAMLEERENSG00000267274,CTD-2006C1.12-0.54781.5014e-063.9158e-12-0.5278imageNBCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;KHDRBS1;LSM11;NOP56;SLTM;SMNDC1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000196757,ZNF700-0.53861.1101e-051.7493e-11-0.5139imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_IL2_STAT5_SIGNALING
chr19:11926444-11929455:+LAMLEERENSG00000147789,ZNF7-0.51787.1357e-058.0895e-09-0.4492imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TIA1;TROVE2;YWHAGNAMonocytesGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr19:11926444-11929455:+LAMLEERENSG00000189180,ZNF33A-0.49131.0695e-042.7532e-09-0.4616imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;HNRNPL;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAEosinophilsGSVA_HALLMARK_NOTCH_SIGNALING
chr19:11926444-11929455:+LAMLEERENSG00000272140,RP11-574K11.29-0.50081.4348e-048.1023e-10-0.4751imageNBUD13;CPSF6;CSTF2T;ELAVL1;GTF2F1;HNRNPA1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;LSM11;NOP56;SLTM;SMNDC1;SRSF1;SRSF9;TAF15;U2AF2;XRN2;RBFOX2;RBM27;TIA1;TROVE2NAT_cells_CD4_naiveGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000250903,GMDS-AS1-0.48534.9949e-041.0144e-08-0.4466imageNADAR;BCCIP;BUD13;CPSF6;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;ILF3;KHDRBS1;LSM11;NOP56;SAFB2;SLTM;SMNDC1;SND1;SRSF1;SRSF9;TAF15;TNRC6A;U2AF2;XRN2;FXR2;GNL3;KHSRP;NONO;RBFOX2;RBM27;TARBP2;TIA1;TROVE2;YWHAGNAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000180855,ZNF443-0.47494.9949e-045.0499e-08-0.4270imageNBUD13;CSTF2T;ELAVL1;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPU;HNRNPUL1;IGF2BP2;KHDRBS1;NOP56;SAFB2;SLTM;SRSF1;SRSF9;TAF15;U2AF2;HNRNPL;KHSRP;NONO;RBFOX2;TIA1ZNF443MonocytesGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB
chr19:11926444-11929455:+LAMLEERENSG00000263477,RP11-338L22.2-0.47445.3780e-043.8511e-08-0.4304imageNELAVL1;NOP56NAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000265713,RP11-82O19.2-0.46128.5624e-044.2849e-10-0.4819imageNNNAT_cells_gamma_deltaGSVA_HALLMARK_UV_RESPONSE_UP
chr19:11926444-11929455:+LAMLEERENSG00000225891,RP3-476K8.3-0.47448.5624e-045.8098e-08-0.4253imageNCSTF2T;ELAVL1;HNRNPA1;HNRNPA2B1;HNRNPC;IGF2BP2;SLTM;SRSF1;TAF15;U2AF2;RBFOX2;TIA1;TROVE2NANeutrophilsGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSE

More results



Top

4. Enriched editing regions and immune related splicing for ZNF700


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

5. Enriched editing regions and immune infiltration for ZNF700


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr19:11930696-11935452:+BRCAEERT_cells_CD4_naive2.1412e-020.3991image
ENSG00000196757.6,ZNF700BRCAEAGNK_cells_activated3.3167e-020.1616image
ENSG00000196757.6,ZNF700COADEAGDendritic_cells_activated2.0732e-030.6203image
chr19:11926444-11929455:+ESCAEERT_cells_CD4_memory_activated4.1197e-02-0.2412image
chr19:11930696-11935452:+ESCAEERMacrophages_M04.9548e-02-0.2276image
ENSG00000196757.6,ZNF700ESCAEAGT_cells_CD4_memory_activated1.7268e-03-0.3008image
ENSG00000196757.6,ZNF700KIRCEAGT_cells_regulatory_(Tregs)2.3832e-03-0.4162image
ENSG00000196757.6,ZNF700KIRPEAGNK_cells_resting5.0473e-030.5065image
chr19:11926444-11929455:+LAMLEERNK_cells_activated1.2220e-030.2616image
ENSG00000196757.6,ZNF700LAMLEAGMast_cells_resting3.1470e-03-0.2396image
ENSG00000196757.6,ZNF700LUADEAGT_cells_follicular_helper5.4824e-03-0.4475image
chr19:11926444-11929455:+OVEERT_cells_regulatory_(Tregs)4.3354e-02-0.3340image
chr19:11930696-11935452:+OVEERMast_cells_activated6.4389e-030.4788image
chr19:11926444-11929455:+STADEERT_cells_CD4_memory_activated1.2797e-030.2668image
ENSG00000196757.6,ZNF700STADEAGT_cells_regulatory_(Tregs)2.9578e-02-0.1535image


Top

6. Enriched editing regions and immune gene sets for ZNF700


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr19:11930696-11935452:+BRCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER4.7538e-050.6468image
ENSG00000196757.6,ZNF700BRCAGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG3.4007e-02-0.1608image
chr19:11926444-11929455:+BRCAGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEER2.3071e-020.3779image
ENSG00000196757.6,ZNF700COADGSVA_HALLMARK_BILE_ACID_METABOLISMEAG3.2423e-03-0.5987image
chr19:11926444-11929455:+ESCAGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEER1.7654e-020.2789image
ENSG00000196757.6,ZNF700KIRCGSVA_HALLMARK_ANDROGEN_RESPONSEEAG7.6880e-030.3691image
ENSG00000196757.6,ZNF700LAMLGSVA_HALLMARK_COAGULATIONEAG7.5787e-100.4758image
chr19:11930696-11935452:+LAMLGSVA_HALLMARK_IL2_STAT5_SIGNALINGEER7.2136e-050.3193image
chr19:11926444-11929455:+LAMLGSVA_HALLMARK_UV_RESPONSE_UPEER3.1134e-060.3702image
ENSG00000196757.6,ZNF700LUADGSVA_HALLMARK_SPERMATOGENESISEAG2.9589e-02-0.3580image
ENSG00000196757.6,ZNF700OVGSVA_HALLMARK_COAGULATIONEAG4.4225e-020.2749image
chr19:11930696-11935452:+OVGSVA_HALLMARK_KRAS_SIGNALING_DNEER4.2399e-020.3668image
chr19:11930696-11935452:+STADGSVA_HALLMARK_PROTEIN_SECRETIONEER3.2137e-050.3304image
ENSG00000196757.6,ZNF700STADGSVA_HALLMARK_APOPTOSISEAG1.8128e-040.2611image
chr19:11926444-11929455:+STADGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER6.9379e-040.2804image


Top

7. Enriched editing regions and drugs for ZNF700


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
chr19:11930696-11935452:+BRCAEtoposideEER2.7955e-040.5926image
ENSG00000196757.6,ZNF700BRCABMS.708163EAG5.4129e-03-0.2100image
chr19:11926444-11929455:+BRCALFM.A13EER1.3153e-020.4094image
ENSG00000196757.6,ZNF700COADMG.132EAG1.4167e-030.6375image
chr19:11930696-11935452:+ESCAGW.441756EER2.5463e-020.2579image
chr19:11926444-11929455:+ESCAAxitinibEER9.7031e-030.3029image
ENSG00000196757.6,ZNF700KIRCBMS.708163EAG3.9594e-03-0.3966image
ENSG00000196757.6,ZNF700KIRPMidostaurinEAG1.3878e-02-0.4518image
ENSG00000196757.6,ZNF700LAMLA.770041EAG3.3686e-07-0.4022image
chr19:11930696-11935452:+LAMLCGP.082996EER6.8460e-04-0.2751image
chr19:11926444-11929455:+LAMLDasatinibEER1.0672e-07-0.4175image
ENSG00000196757.6,ZNF700LUADBI.D1870EAG1.0885e-020.4139image
ENSG00000196757.6,ZNF700LUSCAICAREAG3.9584e-02-0.3911image
chr19:11930696-11935452:+OVCGP.60474EER1.6287e-03-0.5422image
chr19:11930696-11935452:+STADFTI.277EER5.0581e-04-0.2788image
ENSG00000196757.6,ZNF700STADAUY922EAG1.2258e-03-0.2265image
chr19:11926444-11929455:+STADBortezomibEER4.4989e-03-0.2363image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType